Literature DB >> 11782856

Serum hepatocyte growth factor levels are increased in patients with congestive heart failure.

S Ueno1, U Ikeda, Y Hojo, H Arakawa, M Nonaka, K Yamamoto, K Shimada.   

Abstract

BACKGROUND: Hepatocyte growth factor (HGF) is a potent endothelial cell-specific mitogen. We investigated the clinical importance of HGF in congestive heart failure (CHF). METHODS AND
RESULTS: Thirty-five patients with acute exacerbation of CHF and 7 control subjects were examined. Serum and peripheral blood mononuclear cells (PBMCs) were isolated from peripheral blood on days 1, 7, and 14 after admission. PBMCs were cultured at a density of 1 x 10(7) cells/mL for 24 hours. HGF levels in serum and the PBMC culture medium and serum interleukin 6 (IL-6) levels were measured by enzyme-linked immunosorbent assay. Serum HGF levels in patients with CHF were markedly increased at admission compared with those in control subjects and gradually returned to control levels during hospitalization. HGF levels in the PBMC culture medium were also significantly increased in CHF patients compared with control subjects. There was a positive correlation between HGF levels in serum or those in the PBMC culture medium and serum IL-6 levels. HGF levels in serum and the culture medium were not notably different between CHF patients regularly treated with and without angiotensin-converting enzyme inhibitors.
CONCLUSIONS: HGF levels in serum are increased in patients with acute exacerbation of CHF.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11782856     DOI: 10.1054/jcaf.2001.27686

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  5 in total

1.  Serum Hepatocyte Growth Factor Is Probably Associated With 3-Month Prognosis of Acute Ischemic Stroke.

Authors:  Zhengbao Zhu; Tan Xu; Daoxia Guo; Xinfeng Huangfu; Chongke Zhong; Jingyuan Yang; Aili Wang; Chung-Shiuan Chen; Yanbo Peng; Tian Xu; Jinchao Wang; Yingxian Sun; Hao Peng; Qunwei Li; Zhong Ju; Deqin Geng; Jing Chen; Yonghong Zhang; Jiang He
Journal:  Stroke       Date:  2018-01-10       Impact factor: 7.914

Review 2.  Novel therapy for myocardial infarction: can HGF/Met be beneficial?

Authors:  V Sala; T Crepaldi
Journal:  Cell Mol Life Sci       Date:  2011-02-17       Impact factor: 9.261

3.  hHGF overexpression in myoblast sheets enhances their angiogenic potential in rat chronic heart failure.

Authors:  Antti Siltanen; Katsukiyo Kitabayashi; Päivi Lakkisto; Johanna Mäkelä; Tommi Pätilä; Masamichi Ono; Ilkka Tikkanen; Yoshiki Sawa; Esko Kankuri; Ari Harjula
Journal:  PLoS One       Date:  2011-04-26       Impact factor: 3.240

4.  In vitro hepatic trans-differentiation of human mesenchymal stem cells using sera from congestive/ischemic liver during cardiac failure.

Authors:  Dillip Kumar Bishi; Santosh Mathapati; Kotturathu Mammen Cherian; Soma Guhathakurta; Rama Shanker Verma
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

5.  Hepatocyte growth factor predicts failure of Fontan circulation.

Authors:  Takuro Kojima; Moe Taki; Koichi Toda; Shota Muraji; Shigeki Yoshiba; Toshiki Kobayshi; Naokata Sumitomo
Journal:  ESC Heart Fail       Date:  2020-09-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.